CORC

在结果中检索

CORC

浏览/检索结果: 共22条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Tislelizumab for Relapsed/Refractory Classical Hodgkin Lymphoma: 3-Year Follow-up and Correlative Biomarker Analysis 期刊论文
CLINICAL CANCER RESEARCH, 2022, 卷号: 28
作者:  Song, Yuqin;  Gao, Quanli;  Zhang, Huilai;  Fan, Lei;  Zhou, Jianfeng
收藏  |  浏览/下载：29/0  |  提交时间：2022/05/05
Tislelizumab (BGB-A317) for relapsed/refractory (R/R) classical Hodgkin lymphoma (cHL): Long-term follow-up efficacy and safety results from a phase 2 study. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Song, Yuqin;  Gao, Quanli;  Zhang, Huilai;  Fan, Lei;  Zhou, Jianfeng
收藏  |  浏览/下载：28/0  |  提交时间：2022/01/10
Phenylboronic acid-functionalized polyamidoamine-mediated miR-34a delivery for the treatment of gastric cancer 期刊论文
BIOMATERIALS SCIENCE, 2019, 卷号: 7, 期号: 4
作者:  Song, Zheyu;  Liang, Xiao;  Wang, Yudi;  Han, Haobo;  Yang, Jiebing
收藏  |  浏览/下载：11/0  |  提交时间：2019/12/05
Treatment of relapsed or refractory classical Hodgkin lymphoma with the anti-PD-1, tislelizumab: results of a phase 2, single-arm, multicenter study 期刊论文
2019
作者:  Song Yuqin;  Gao Quanli;  Zhang Huilai;  Fan Lei;  Zhou Jianfeng
收藏  |  浏览/下载：16/0  |  提交时间：2020/01/03
Tislelizumab (BGB-A317) for Relapsed/Refractory Classical Hodgkin Lymphoma: Preliminary Efficacy and Safety Results from a Phase 2 Study 期刊论文
BLOOD, 2018, 卷号: 132
作者:  Song, Yuqin;  Gao, Quanli;  Zhang, Huilai;  Fan, Lei;  Zhou, Jianfeng
收藏  |  浏览/下载：11/0  |  提交时间：2019/12/05
Tislelizumab (BGB-A317) for Relapsed/Refractory Classical Hodgkin Lymphoma: Preliminary Efficacy and Safety Results from a Phase 2 Study 会议论文
作者:  Song, Yuqin;  Gao, Quanli;  Zhang, Huilai;  Fan, Lei;  Zhou, Jianfeng
收藏  |  浏览/下载：5/0  |  提交时间：2019/12/05
Efficacy of Caspofungin in Unclassified Invasive Fungal Infection Cases: A Retrospective Analysis of Patients with Hematological Malignancies in China 期刊论文
2018, 卷号: 24, 页码: 5258-5270
作者:  Zhang, Xiaohui;  Hu, Jiong;  Hu, Yu;  Huang, He;  Jin, Jie
收藏  |  浏览/下载：21/0  |  提交时间：2020/01/03
Primary antifungal prophylaxis: decrease of invasive fungal disease incidence and reduction of risk factors in haematological patients in a 5-year retrospective study 期刊论文
2018, 卷号: 48, 期号: 6, 页码: 713-720
作者:  Li, Yan;  Liu, Mingjuan;  Zhai, Bing;  Zhao, Xiaoli;  Wang, Lijun
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03
Tislelizumab (BGB-A317) for Relapsed/Refractory Classical Hodgkin Lymphoma: Preliminary Efficacy and Safety Results from a Phase 2 Study 期刊论文
2018, 卷号: 132
作者:  Song, Yuqin;  Gao, Quanli;  Zhang, Huilai;  Fan, Lei;  Zhou, Jianfeng
收藏  |  浏览/下载：8/0  |  提交时间：2020/01/03
Tislelizumab (BGB-A317) for Relapsed/Refractory Classical Hodgkin Lymphoma: Preliminary Efficacy and Safety Results from a Phase 2 Study 会议论文
BLOOD, 2018-11-29
作者:  Song, Yuqin;  Gao, Quanli;  Zhang, Huilai;  Fan, Lei;  Zhou, Jianfeng
收藏  |  浏览/下载：15/0  |  提交时间：2020/01/03

©版权所有 ©2017 CSpace - Powered by CSpace